Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2013 1
2014 4
2015 3
2016 3
2017 2
2018 5
2019 4
2020 2
2021 4
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Engraftment in NSGSCF mice correlates with the WHO category and prognosis in systemic mastocytosis.
Willmann M, Peter B, Slavnitsch K, Berger D, Witzeneder N, Stefanzl G, Eisenwort G, Ivanov D, Sadovnik I, Hadzijusufovic E, Greiner G, Bernthaler T, Hoermann G, Dahlhoff M, Rülicke T, Valent P. Willmann M, et al. Among authors: stefanzl g. Leukemia. 2023 May;37(5):1162-1165. doi: 10.1038/s41375-023-01871-7. Epub 2023 Mar 14. Leukemia. 2023. PMID: 36918646 Free PMC article. No abstract available.
Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.
Degenfeld-Schonburg L, Gamperl S, Stefanzl G, Schruef AK, Sadovnik I, Bauer K, Smiljkovic D, Eisenwort G, Peter B, Greiner G, Hadzijusufovic E, Schwaab J, Sperr WR, Hoermann G, Kopanja S, Szépfalusi Z, Hoetzenecker K, Jaksch P, Reiter A, Arock M, Valent P. Degenfeld-Schonburg L, et al. Among authors: stefanzl g. Am J Cancer Res. 2023 Feb 15;13(2):355-378. eCollection 2023. Am J Cancer Res. 2023. PMID: 36895976 Free PMC article.
N-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.
Graf I, Greiner G, Marculescu R, Gleixner KV, Herndlhofer S, Stefanzl G, Knoebl P, Jäger U, Hauswirth A, Schwarzinger I, Thalhammer R, Kundi M, Hoermann G, Mitterbauer-Hohendanner G, Valent P, Sperr WR. Graf I, et al. Among authors: stefanzl g. Am J Hematol. 2023 Feb;98(2):290-299. doi: 10.1002/ajh.26805. Epub 2023 Jan 1. Am J Hematol. 2023. PMID: 36588398 Free PMC article.
Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils.
Smiljkovic D, Herrmann H, Sadovnik I, Gamperl S, Berger D, Stefanzl G, Eisenwort G, Hoermann G, Kopanja S, Dorofeeva Y, Focke-Tejkl M, Jaksch P, Hoetzenecker K, Szepfalusi Z, Valenta R, Arock M, Valent P. Smiljkovic D, et al. Among authors: stefanzl g. J Allergy Clin Immunol. 2023 Jan;151(1):202-211. doi: 10.1016/j.jaci.2022.07.018. Epub 2022 Aug 8. J Allergy Clin Immunol. 2023. PMID: 35953001 Free article.
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.
Schneeweiss-Gleixner M, Filik Y, Stefanzl G, Berger D, Sadovnik I, Bauer K, Smiljkovic D, Eisenwort G, Witzeneder N, Greiner G, Hoermann G, Schiefer AI, Schwaab J, Jawhar M, Reiter A, Sperr WR, Arock M, Valent P, Gleixner KV. Schneeweiss-Gleixner M, et al. Among authors: stefanzl g. Cancers (Basel). 2022 Jun 23;14(13):3070. doi: 10.3390/cancers14133070. Cancers (Basel). 2022. PMID: 35804842 Free PMC article.
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.
Peter B, Eisenwort G, Sadovnik I, Bauer K, Willmann M, Rülicke T, Berger D, Stefanzl G, Greiner G, Hoermann G, Keller A, Wolf D, Čulen M, Winter GE, Hoffmann T, Schiefer AI, Sperr WR, Zuber J, Mayer J, Valent P. Peter B, et al. Among authors: stefanzl g. Am J Hematol. 2022 Sep;97(9):1215-1225. doi: 10.1002/ajh.26650. Epub 2022 Jul 18. Am J Hematol. 2022. PMID: 35794848 Free PMC article.
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.
Berger D, Bauer K, Kornauth C, Gamperl S, Stefanzl G, Smiljkovic D, Sillaber C, Bettelheim P, Knöbl P, Schiefer AI, Greiner G, Thalhammer R, Hoermann G, Schwarzinger I, Staber PB, Sperr WR, Valent P. Berger D, et al. Among authors: stefanzl g. Neoplasia. 2021 Dec;23(12):1183-1191. doi: 10.1016/j.neo.2021.09.010. Epub 2021 Oct 31. Neoplasia. 2021. PMID: 34731787 Free PMC article.
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.
Gleixner KV, Filik Y, Berger D, Schewzik C, Stefanzl G, Sadovnik I, Degenfeld-Schonburg L, Eisenwort G, Schneeweiss-Gleixner M, Byrgazov K, Sperr WR, Mayer J, Lion T, Valent P. Gleixner KV, et al. Among authors: stefanzl g. Am J Cancer Res. 2021 Sep 15;11(9):4470-4484. eCollection 2021. Am J Cancer Res. 2021. PMID: 34659899 Free PMC article.
32 results